PAIN TRIGGERS
Pharmacies withhold stock information or refuse to disclose if they can fill controlled substance prescriptions.
Difficulty finding Adderall and other ADHD medications in stock due to ongoing shortages.
SaaS· college students with ADHDPain 8.00/10WTP 7.0/10Market 8.0/10Validation 9.0Confidence 95%Aug 20, 2026
PharmaLocate: Controlled Substance Stock Tracker for ADHD Patients
Patients struggling with ADHD medication shortages cannot reliably locate pharmacies with their prescribed Adderall in stock because pharmacies frequently provide vague or unhelpful answers due to controlled substance security policies.
healthcaremobile-appproductivitysaasstudentsworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Patients struggling with ADHD medication shortages cannot reliably locate pharmacies with their prescribed Adderall in stock, and pharmacies often provide vague or unhelpful answers due to supply policies.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Recently diagnosed 19M in NYC — struggling to find Adderall before college starts. Advice?
ADHD16
Pharmacies being purposely vague tend to be because they don’t want to take on more scripts.
commentI’m a pharmacist, it heavily depends on dose and form. Many of the ER forms go in and out of back order. Pharmacies being purposely vague tend to be because they don’t want to take on more scripts. You can try independents or try multiple chains but other than that your other option is temporary dose swaps or things like two lower dose pill/tabs once daily
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
college students with ADHDA D H D Medication Patients
Patients and students struggling to find in-stock stimulant medication locally due to pharmacy policies and supply chain shortages.
Context
Locate a reliable pharmacy supply of prescribed medication before starting the college semester.
Calling multiple independent and chain pharmacies manually to check stock.
Considering alternative dosages, formulations, or temporary dose swaps recommended by pharmacists.
Current Workarounds
Calling multiple independent and chain pharmacies manually every month
Accepting alternative dosages or temporary formulation swaps through trial-and-error
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard pharmacy inventory systems and staff do not provide transparent, real-time stock availability for controlled substances to patients.
Prescribers and patients lack an efficient mechanism to track active supply across local pharmacies during nationwide shortages.
OPPORTUNITY & VALUE
Why Now
Repeated complaints regarding pharmacies withholding stock information and ongoing difficulties finding Adderall.
Value Proposition
Purpose-built for controlled substances and community-driven verification, bypassing opaque standard inventory calls.
Product Direction
A crowd-sourced and verified stock-tracking platform and community-driven alert network specifically designed to map local controlled substance availability transparently for patients.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moIndividual patient tier with real-time alerts
Model
SaaS subscription
WILLINGNESS TO PAY
Patients spend hours calling pharmacies or risk missing doses and academic deadlines, making a low monthly fee an easy trade-off for saved time and reduced anxiety.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Find your prescription in stock before calling five pharmacies.”
A crowd-sourced and verified stock-tracking platform and community-driven alert network specifically designed to map local controlled substance availability transparently for patients.
Core Features
Community-verified local pharmacy stock status updates
Secure patient-reported availability logs and alerts
Weekly Roadmap
1
W1-W2
Core data capture model and user authentication established.
- •Design database schema for pharmacy locations and drug items
- •Build basic user submission flow for stock updates
- •Implement secure user authentication
2
W3-W4
Alert engine and search filtering functional.
- •Build geographic search and filtering by medication type
- •Implement SMS/push notification alert triggers
- •Add verification scoring for user reports
3
W5
Payment integration and beta tester onboarding.
- •Integrate Stripe for monthly subscription billing
- •Recruit 20 beta users from ADHD support communities
- •Refine UI based on initial feedback
4
W6
Public launch and initial user acquisition.
- •Launch on relevant student and healthcare communities
- •Monitor alert delivery performance and server stability
- •Track subscription conversion rates
Launch Strategy
Target student health centers, Reddit communities like r/ADHD, and digital health forums.
RISKS & ASSUMPTIONS
Top Risks
Pharmacy security policy friction
Pharmacies may actively discourage or block public tracking tools for controlled substances to prevent targeted theft risks.
Stale crowdsourced data
High-demand medications sell out instantly, causing user frustration if reported stock is out of date.
Regulatory and compliance complexity
Handling medication availability data touches sensitive health boundaries requiring careful privacy and compliance handling.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "healthcare", "mobile-app", "productivity", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "PharmaLocate: Controlled Substance Stock Tracker for ADHD Patients" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for healthcare?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.